This inventor holds 6 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Glaxosmithkline Intellectual Property Development Limited, Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- King of Prussia, PA (US) (2021)
- Collegeville, PA (US) (2020 - 2024)
Company Filing History:


Years Active: 2020-2024
Title: The Innovations of Jay M Matthews
Introduction
Jay M Matthews is a notable inventor based in Collegeville, PA, with a remarkable portfolio of six patents. His work primarily focuses on pharmaceutical innovations that contribute to advancements in medical science.
Latest Patents
Among his latest patents, Matthews has developed hydroxypyridoxazepines as NRF2 activators. This invention relates to hydroxypyridoxazepine compounds, methods of making them, pharmaceutical compositions containing them, and their use as Nrf2 activators. In particular, the invention includes compounds of Formula (I), along with their pharmaceutically acceptable salts, tautomers, or hydrates. Another significant patent involves TRPV4 antagonists, which pertains to pyrrolidine sulfonamide analogs, pharmaceutical compositions containing them, and their application as TRPV4 antagonists.
Career Highlights
Matthews has had a distinguished career, working with prominent organizations such as GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline Intellectual Property (No. 2) Limited. His contributions to these companies have been instrumental in advancing their research and development efforts.
Collaborations
Throughout his career, Matthews has collaborated with notable colleagues, including Carl A Brooks and Brian Griffin Lawhorn. These partnerships have fostered innovation and have led to significant advancements in their respective fields.
Conclusion
Jay M Matthews exemplifies the spirit of innovation through his impactful patents and collaborations in the pharmaceutical industry. His work continues to influence the development of new medical therapies and compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile